AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today offered commentary on a new article in the Journal of General Internal Medicine linking COVID-19 to increased risk of Myalgic ...
“We are being very careful with regard to diagnosing our patients with POTS, as we know COVID-19 can cause blood clots or scars in the lungs, which can cause symptoms similar to POTS but would require ...